Ligand Buying Pharmacopeia in Deal Worth up to $70M

San Diego-based Ligand Pharmaceuticals Inc. has agreed to buy Pharmacopeia Inc. in a deal valued up to $70 million, with $15 million of that payment contingent on whether Ligand enters into a deal for Pharmacopeia's DARA program by the end of 2011. (BioWorld Today)